在缺血性中风中评估托西利祖马布:SPAN多中心试验的发现
Anjali Chauhan1, Eunyoung Angela Lee1, Rakesh B Patel2
1Department of Neurology, McGovern Medical School, University of Texas HSC, Houston, TX, USA.
Neuropharmacology
|December 7, 2025
概括
托西利祖马布 (TCZ) 在中风后对老年小鼠和雄性高血压大鼠表现出功能改善,但没有减少长期的大脑组织损失. 进一步研究IL-6受体抑制用于中风恢复是有必要的.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 干白素-6 (IL-6) 信号传递是中风病理生理学的关键因素,高水平与患者的不良结果有关.
- 准IL-6信号传递是一种潜在的治疗策略,可以减少中风引起的损伤并促进恢复.
研究的目的:
- 在临床前中风模型中评估IL-6受体抑制剂托西利祖马布 (TCZ) 的疗效.
- 评估TCZ对中脑动脉封闭 (MCAO) 后的感觉运动恢复和脑组织损失的影响.
主要方法:
- 对701只接受MCAO治疗的动物 (老鼠和自发高血压大鼠) 的行为和MRI数据的分析.
- 用液 (安慰剂) 或TCZ治疗,根据物种不同剂量.
- 通过MRI形态测量评估长期的感觉运动功能和脑损伤体积.
主要成果:
- 在一般小鼠队列中,TCZ没有显著改善整体感觉运动恢复或减少大脑组织损失.
- 在接受TCZ治疗的老年小鼠中观察到适度的运动功能的改善.
- 在自发高血压的老鼠,特别是雄性老鼠中,TCZ增强了感觉运动功能,并提供了早期的大脑保护,但没有防止后来的组织缩.
结论:
- 用TCZ阻断IL-6受体在特定的动物模型 (老化小鼠,雄性高血压大鼠) 中显示出功能益处,但缺乏对大脑组织损失的持久影响.
- 这些发现支持IL-6信号作为中风恢复的治疗点.
- 建议在中风治疗策略中进一步研究IL-6受体抑制.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
199
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
Ischemic Heart Disease: Overview
2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
457
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
457
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K


